Asia Pacific Neurosurgical Robotics Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Component [Equipment/System (Robot Machines, Navigation System, Planner & Simulators, and Others), Accessories, and Services], Application [Spinal (La

Asia Pacific Neurosurgical Robotics Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Component [Equipment/System (Robot Machines, Navigation System, Planner & Simulators, and Others), Accessories, and Services], Application [Spinal (Laminectomy, Discectomy, Spinal Fusion, Disc Replacement, Foraminotomy, and Others) and Cranial (Craniotomy, Brain Biopsy, Thermal ablation of Seizure and Others)], Surgery Type (Minimally Invasive and Open Surgery), and End User (Hospitals, Specialty Clinics, and Others)

The neurosurgical robotics market in Asia Pacific is expected to grow from US$ 438.08 million in 2022 to US$ 1,127.73 million by 2028. It is estimated to grow at a CAGR of 17.1% from 2022 to 2028.

Rising Number of Product Developments and Approvals

The neurosurgical robotics market has the presence of many small and big companies. New component launch, regional expansion, product approval, and technological advancement are among the strategies adopted by companies to enlarge their market shares. Neurosurgical robots have become safer and more effective than ever with continuous innovations and technological advancements, boosting their acceptance among the masses. The active participation of market players in development activities, followed by increased product approvals by regulatory bodies, would offer lucrative opportunities for the growth of the neurosurgical robotics market in the coming years.

Market Overview



APAC is the fastest-growing regional market for neurosurgical robotics. The APAC neurosurgical robotics market is segmented into China, Japan, India, South Korea, Australia, and the Rest of APAC. APAC held a market share of 22.49% in 2021, owing to emerging market players in APAC countries, growing prevalence and incidence of neurological disorders requiring surgical procedures, increasing demand for minimally invasive and precise surgery, and introduction of advanced molecular platforms. These factors are expected to propel the APAC neurosurgical robotics market in the coming years.

Asia Pacific Neurosurgical Robotics Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Neurosurgical Robotics Market Segmentation

The Asia Pacific neurosurgical robotics market is segmented into component, application, surgery type, end user, and country.

Based on component type, the Asia Pacific neurosurgical robotics market is segmented into equipment/system, accessories, and services. The equipment/system segment is further segmented into robot machines, navigation system, planner & simulators, and others. The accessories segment is anticipated to hold the largest share of the market in 2022. The Asia Pacific neurosurgical robotics market, based on application, is segmented into spinal and cranial. Spinal application is further segmented into spinal fusion, laminectomy, disc replacement, discectomy, foraminotomy, and others. The cranial segment is subsegmented into brain biopsy, thermal ablation of seizure, surgical treatment of movement disorders, and others. In 2022, the spinal segment is anticipated to hold the largest share of the market, by application.

The Asia Pacific neurosurgical robotics market, based on surgery type, is segmented into open and minimally invasive. In 2022, the minimally invasive segment is anticipated to hold a larger share of the market.

Based on end user, the Asia Pacific neurosurgical robotics market is segmented into hospitals, specialty centers, and others. In 2022, the hospitals segment is anticipated to hold the largest share of the market. Based on country, the market is segmented into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. China is expected to dominate the market in 2022. Accuray Incorporated; B. Braun Melsungen AG; Brainlab AG; Brain Navi Biotechnology Co., Ltd.; Globus Medical, Inc.; Medtronic; Renishaw plc; NuVasive, Inc.; and Zimmer Biomet are among the leading companies operating in the neurosurgical robotics market in the region.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific neurosurgical robotics market
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific neurosurgical robotics market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the neurosurgical robotics market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution